Pediatrix Medical Group Inc (NYSE:MD)
$ 15.5 -0.46 (-2.88%) Market Cap: 1.33 Bil Enterprise Value: 1.83 Bil PE Ratio: 0 PB Ratio: 1.82 GF Score: 69/100

MEDNAX Inc at Bank of America Merrill Lynch Leveraged Finance Conference Transcript

Dec 03, 2019 / 07:50PM GMT
Release Date Price: $25.7 (-1.34%)
Larry Alan Bland
BofA Merrill Lynch, Research Division - MD and Head of United States Credit Research

Our next presentation. And with our presenter Charlie Lynch, Vice President of Strategy and Investor Relations for MEDNAX. Thank you, again, for joining. And I'll turn it over to Charlie. Thank you, Charlie.

Charles W. Lynch
MEDNAX, Inc. - VP of Strategy & IR

Thanks, Larry. Thanks for having us. Again, this is always a great session. And welcome, everyone, to warm and sunny Florida, except for us, who live in Florida where it's cold.

So I just have a couple of slides, I'd like to speak off to -- off of today and kind of go through some things that we've talked about a lot through the course of this year and up to and including when we reported our third quarter results about a month ago. For those of you who aren't that familiar with MEDNAX, we are, at our heart, a physician services organization. We were founded in 1979 with 1 neonatology practice down here in South Florida. And fast forward to today, we now encompass well over 4,000 physicians

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot